MRN: Harnessing 2D Vision Foundation Models for Diagnosing Parkinson's Disease with Limited 3D MR Data
This work addresses the clinical need for automated Parkinson's disease diagnosis with limited data, representing an incremental improvement by adapting existing 2D models to 3D medical imaging.
The paper tackled the problem of diagnosing Parkinson's disease using limited 3D MR data by leveraging 2D vision foundation models to process key ROIs and achieved an accuracy of 86.0%, outperforming the second-place method by 5.5% in a challenge.
The automatic diagnosis of Parkinson's disease is in high clinical demand due to its prevalence and the importance of targeted treatment. Current clinical practice often relies on diagnostic biomarkers in QSM and NM-MRI images. However, the lack of large, high-quality datasets makes training diagnostic models from scratch prone to overfitting. Adapting pre-trained 3D medical models is also challenging, as the diversity of medical imaging leads to mismatches in voxel spacing and modality between pre-training and fine-tuning data. In this paper, we address these challenges by leveraging 2D vision foundation models (VFMs). Specifically, we crop multiple key ROIs from NM and QSM images, process each ROI through separate branches to compress the ROI into a token, and then combine these tokens into a unified patient representation for classification. Within each branch, we use 2D VFMs to encode axial slices of the 3D ROI volume and fuse them into the ROI token, guided by an auxiliary segmentation head that steers the feature extraction toward specific brain nuclei. Additionally, we introduce multi-ROI supervised contrastive learning, which improves diagnostic performance by pulling together representations of patients from the same class while pushing away those from different classes. Our approach achieved first place in the MICCAI 2025 PDCADxFoundation challenge, with an accuracy of 86.0% trained on a dataset of only 300 labeled QSM and NM-MRI scans, outperforming the second-place method by 5.5%.These results highlight the potential of 2D VFMs for clinical analysis of 3D MR images.